Vanguard Group Inc Dare Bioscience, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DARE
# of Institutions
20Shares Held
7.13MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA1.01MShares$3.92 Million0.0% of portfolio
-
Amh Equity LTD924KShares$3.59 Million0.44% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny779KShares$3.03 Million0.0% of portfolio
-
State Street Corp Boston, MA282KShares$1.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY204KShares$792,1280.0% of portfolio
About Dare Bioscience, Inc.
- Ticker DARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,820,896
- Market Cap $330M
- Description
- Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...